Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 | P03952 | 2/20 | 0.38 |
| ▸ | KLK1 | P06870 | 2/20 | 0.38 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | USP2 | O75604 | 3/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.34 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | PDE2A | O00408 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19905118 | 1.00 | KLKB1 (0.38) | KLKB1KLK1MAPK8ALDH1A1USP2 | |
| SCHEMBL19355439 | 0.90 | USP2 (0.37) | KLKB1KLK1ALDH1A1USP2CYP1A2 | |
| SCHEMBL19355133 | 0.89 | LRRK2 (0.35) | ALDH1A1USP2CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL19355448 | 0.89 | HDAC6 (0.36) | ALDH1A1USP2CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL19355568 | 0.88 | PRKDC (0.40) | KLKB1KLK1MAPK8ALDH1A1KDM4E | |
| SCHEMBL20373532 | 0.87 | WNT3A (0.39) | ALDH1A1USP2CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL17634921 | 0.86 | PRKDC (0.46) | KLKB1KLK1MAPK8ALDH1A1KDM4E | |
| SCHEMBL17634928 | 0.86 | PRKDC (0.46) | KLKB1KLK1MAPK8ALDH1A1KDM4E | |
| SCHEMBL19355581 | 0.86 | CYP1A2 (0.37) | ALDH1A1USP2CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL20373253 | 0.85 | PRKDC (0.41) | KLKB1KLK1MAPK8ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3459942-B1 | DNA-PK INHIBITORS | VERTEX PHARMA (US) | 2020-12-30 | — | — | EP | disclosed |
| US-20170258789-A1 | DNA-PK INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2017-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170258789-A1 | DNA-PK INHIBITORS | POLK, DTYMK, DCK | KLKB1 119/4885KLK1 441/4885MAPK8 950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.